PharmaShots | Incisive News in 3 Shots

Subscribe Now

Anaptys

Anaptys Acquires Exclusive License for Centessa's BDCA2 Modulator Antibody Portfolio Targeting Autoimmune Diseases

Anaptys Acquires Exclusive License for Centessa's BDCA2 Modulator Antibody Portfolio Targeting Autoimmune Diseases

November 28, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us